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Abstract : The prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is increasing 
rapidly and spreading worldwide, particularly in Asia, compared to other regions. In the last ten years, in our 
hospital, in particular, there has been a < 30% increase. To prevent the spread of ESBL in hospitals and the com-
munity, the ultraviolet (UV) A-light-emitting diode (LED) irradiation device was used to inactivate ESBL-E. coli 
in human livestock and the environment. ESBL-E. coli and E. coli bacterial samples were collected from patients 
at Tokushima University Hospital (Tokushima City, Japan). The UVA-LED irradiation system had 365 nm single 
wavelength, and the current of the circuit was set to 0.23 or 0.50 A consistently. Results demonstrated that UVA-
LED was useful for the inactivation of ESBL-E. coli and E. coli. The minimum energy dosage required to inacti-
vate ESBL-E. coli and E. coli was 40.76 J/cm2 (45 min) in the first type of UVA-LED and 38.85 J/cm2 (5 min) in the 
second type. There were no significant differences between ESBL-E. coli and E. coli. The inactivation of ESBL-E. 
coli was dependent on energy. These findings suggest that UVA-LED with 365 nm single wavelength could be 
useful for surface decontamination in healthcare facilities. J. Med. Invest. 67 : 163-169, February, 2020
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INTRODUCTION
 
Extended-spectrum β-lactamase (ESBL) is a β-lactamase that 
can hydrolyze penicillins, cephalosporins (1) and one or more 
oxyimino-β-lactams (cefotaxime, ceftazidime, and aztreonam) 
(2). For decades, resistance to β-lactams have been dramatically 
increasing, and a significant antimicrobial-resistant pathogen 
has emerged in the developed world. Centers for Disease Control 
and Prevention (CDC) trying to assess and understand why 
infections caused by ESBL-producing Enterobacteriaceae have 
increased since 2012 (3). In 2017, CDC estimated 197,400 cases 
of ESBL-producing Enterobacteriaceae among hospitalized pa-
tients, 9,100 people deaths, and 1.2 billion dollars to healthcare 
costs in the United States (3).
ESBL-producing Escherichia coli (ESBL-Ec) is considered a 
healthcare-associated problem, as outbreaks of infection by this 
organism have been occurring in hospitals or other healthcare 
facilities, such as nursing homes (1,4). The risk factor for the 
development of disease with ESBL-producing bacterial in the 
hospital are patients with prolonged hospitalization (3-5) and 
in whom invasive medical devices such as urinary catheters, 
endotracheal tubes, central venous lines for a prolonged duration 
(4-5). This infection can be spread from one person to another 
through contaminated hands, surfaces, and environments (3-5), 
such as ultrasonography coupling gel in particular intrapartum 
contamination (7) and the washing machine in the pediatric 
hospital ward in Germany (8). Stethoscopes and thermometers 
may also be risk factors in the nursing home (4-6).
Hospital environmental cleaning plays a vital role in the 
termination and reducing of healthcare-associated infections 
(9-12). The high-risk area of pathogen transmission should be 
cleaned and decontamination regularly (9). Traditional cleaning 
methods are currently inefficient for cleanup. New approaches 
have been proposed, including disinfectants, steam, automated 
dispersal systems, and antimicrobial surfaces (9). Each country 
has national standards for hospital environmental cleaning. The 
hospital has different standard specification in each area, such 
as operating theaters, outpatient sections, and non-clinical areas 
(10).
Thus, antibiotic-resistant bacteria have become a new chal-
lenge for disinfection. Besides the well-known shortcomings of 
chlorination, disinfection also has the potential to increase an-
tibiotic-resistant gene transfer if adequate doses are not applied 
(13). As an innovative non-antibiotic approach, ultraviolet (UV) 
irradiation has been investigated as a potential decontaminant 
against environmental pathogens, including the disinfection 
of surfaces, instruments, and air (9). UV light-emitting diodes 
(LEDs) have emerged as the most promising new UV light 
source in the past decade, as they have a longer life and are less 
fragile and free of toxic components (14). UV-LED has three 
different bands depending on the wavelengths : UVC (< 280 
nm), UVB (280–315 nm), and UVA (315–400 nm) (15). The 
mechanisms of the inactivation of microorganisms by UV are 
dependent on the irradiation wavelength, process conditions, 
and different organisms (14-16). Many studies have reported 
that UV-LEDs have been used for many years and at various 
wavelengths and developed as a new method for the inactivation 
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of microorganisms (16). 
Our previous studies have reported that an originally 
developed UVA-LED with a 365 nm irradiation system could 
inactivate bacteria in the environment, in particular, water 
disinfection systems. The UVA-LED irradiation system was 
able to inactivate bacteria (17-20,28), such as V. parahaemolyticus, 
enteropathogenic E. coli, S. aureus, and E. coli DH5∝ at minimum 
energy  315 J/cm2 in 75 min. Inactivation of S. enterica serovar 
enteritidis required energy 672 J/cm2 in 160 min by UVA-LED 
(18). The UVA-LED was reported to induce cellular membrane 
damage and delay growth (21-23). The mechanisms indirectly 
by increasing the levels of reactivating oxygen species, including 
superoxide anion radicals, hydroxyl radicals, hydrogen peroxide, 
and singlet oxygen (18). UVA light exposure resulted in modest 
reductions of vegetative microorganisms and reduced recovery of 
pathogenic bacteria from in-use medical equipment (24).
Here, we explored the effectiveness of UVA-LED irradiation 
to inactivate ESBL-Ec and E. coli from patients at Tokushima 
University Hospital. We investigated how UVA-LED inactivated 
ESBL-Ec and E. coli with different irradiation times and various 
energies. Further, we compared the different effects of UVA-
LED radiation on the inactivation of E. coli and ESBL-Ec.
MATERIALS AND METHODS
Screening and confirmation of ESBL production
Bacterial samples obtained from two compartments were 
clinical isolate strains and food isolate strains. Six E. coli and 
12 ESBL-Ec clinical isolates from patients from December 
2017 to June 2018 at Tokushima University Hospital were 
measured using MALDI Biotyper (Bruker) MALDI-TOF mass 
spectrometer. A confirmation test for ESBL-Ec based on the 
microliquid method of the Clinical and Laboratory Standards 
Institute (CLSI ; M100-S22) was performed. Dry plate E-EP01 
for Gram-negative bacilli was used together with a microbial 
susceptibility analyzer (DPS192iX).
ESBL-Ec food isolates collected from chicken meats were 
purchased from three supermarkets in Tokushima City, 
Tokushima, Japan, from May to June 2018. Two grams of each 
sample was stomached in 18 ml Enterobacteriaceae enrichment 
mannitol broth (Merck, Germany). After incubation at 37°C for 
16 ± 2 h, a loopful of enriched culture was streaked onto MacCon-
key agar (DifcoTM Mac Conkey, Becton, Dickinson and Co., USA) 
containing 1 mg/l CTX (Nihon Becton Dickinson, Tokyo, Japan) 
and incubated at 37°C for 24 h. 
Detection of ESBL-Ec genes
The isolation of ESBL-Ec DNA and DNA sequence was done 
using DNeasy Blood and Tissue Kit (Qiagen). Polymerase chain 
reaction (PCR) was performed using two kinds of multiplex PCR 
using Cica Geneus ESBL Genotype Detection Kit (Kanto Chem-
ical Co., Inc.) to identify ESBL genes, including blaTEM, blaSHV, 
blaCTX-M-1 group, blaCTX-M-2 group, blaCTX-M-8 group, and 
blaCTX-M-9 group.
Antimicrobial susceptibility testing 
All samples of clinical isolates and food isolates were sent to 
the Department of Laboratory Medicine, Tokushima University 
Hospital, for antimicrobial susceptibility testing. A total of 13 
antibiotics were tested : ampicillin, piperacillin-tazobactam, 
cefazolin, cefmetazole, ceftriaxone, flomoxef, aztreonam, imi-
penem, meropenem, cefoperazone/sulbactam, ciprofloxacin, 
gentamicin, and selfamethoxazole-trimethoprim. The minimum 
inhibitory concentration was measured based on the guidelines 
of the CLSI. The disc diffusion method was used, in which 
CPDX inhibited clavulanic acid with AmpC/ESBL disc (Kanto 
Chemical).
UVA-LED irradiation procedure
The UVA-LED (Nichia Corp., Japan) with 365 nm wave-
length was used as the sterilization device. In this experi-
ment, two types of 365 nm UVA-LED were used. The first type 
[NC4U133B (T)] was equipped with eight 365 nm LEDs (Fig. 
1a) (17-19), whereas the second type [NVSU233A (T)-D1)] was 
equipped with three 365 nm LEDs with the lens (Fig. 1c). We 
connected the UVA-LED device with a direct-current power 
supply (Fig. 1b). The current of the circuit was set to 0.23 or 0.50 
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Figure 1.　UVA-LED Irradiation device. The first type of UVA-LED equipped with eight 365 nm LEDs (a), and the 
second type equipped with three 365 nm LEDs with lens (c). The UVA-LED connected to a DC power supply (b), the 
illustration light during the irradiation of the first type UVA-LED light (d), and the second type (f). Colony-forming 
ability assay (g) before and after irradiation.
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Bacteria were cultured in Luria-Bertani (LB) broth (1% tryp-
tone, 1% NaCl, 0.5% yeast extract) at 37°C for 18 h. Cells were 
centrifuged (12,000 rpm, 3 min), washed two times with steril-
ized phosphate-buffered saline (PBS ; pH 7.4), and suspended in 
PBS at an initial concentration of 5 × 104 to 7 × 104 or 5 × 106 to 
7 × 106 colony-forming units/ml. A total of 200 μl bacterial sus-
pension were placed into a disposable 96-well plate (Fig. 1e). The 
distance between the UVA-LED and the surface of the bacterial 
solution was 2 cm. Then, 96-well plates were inserted under the 
sterilization device, and UVA-LED was irradiated (Fig. 1d and 
1f). UVA-LED irradiation was performed at room temperature 
(25°C) in the same room for various periods for 15, 30, and 45 
min in the first type and 5, 10, and 15 min in the second type. 
The UVA-LED devices equipped with a fan and heat sink (Fig. 
1f) for the cooling system. The total energy (J/cm2) was calculat-
ed as irradiance (W/cm2) × exposure time (s) (Table 1).
Determination of the inactivation level
A colony-forming assay determined the inactivation level (Fig. 
1g). After UVA-LED irradiation, bacterial suspensions were 
diluted appropriately, plated on LB agar plates, and incubated 
at 37°C for 18 h. After incubation, the number of colonies was 
counted, and a log survival ratio or an inactivation percentage 
was calculated using the following equation : 
log survival ratio = log (Nt/N0)
where Nt is the colony count of the UV irradiated sample and N0 
is the colony count of the sample before UV irradiation. The in-
activation efficiency reached a minimum -3 log reduction. These 
data indicate that UVA-LED irradiation can inactivation the 
bacteria (25-26). 
Statistical analysis
Every isolated strain was regarded as a sample. Each data 
in this study represents the average ± standard deviation of 
three replicates. Analysis of covariance was used to analyze the 
differences among group means in each sample strain. p < 0.05 
was considered statistically significant. Statistical analysis was 
performed using IBM SPSS Statistics version 25 software.
RESULTS
Characteristics of ESBL-Ec
The incidence rate of ESBL-producing Enterobacteriaceae in 
the last 10 years from 2010 to 2018 in our hospital has fluctuated 
(10–25%) ; however, overall, it tended to increase. The percent-
age of ESBL-Ec was 19.4% in 2014, 17.8% in 2015, 14% in 2016, 
19.7% in 2017, and 22.2% in 2018 (data not shown).
PCR analysis showed that 12 ESBL-Ec clinical isolates 
(Table 2a) positive for ESBL production harbored blaCTX-M-9 
(75% ; n = 9) and 3 isolates harbored a combination of blaTEM 
and/or blaCTX-M-1 (25% ; n = 3), whereas 6 ESBL-Ec food 
isolates (Table 2b) harbored blaTEM (66.67% ; n = 4) and 2 
isolates harbored a combination of blaTEM and/or blaCTX-M-2 
(33.33% ; n = 2).
Six E. coli clinical isolates, 12 ESBL-Ec clinical isolates, and 
6 ESBL-Ec food isolates were tested with 13 antimicrobial 
agents. Six E. coli clinical isolates were susceptible to 11 anti-
microbial agents, except ampicillin (16.67%) and ciprofloxacin 
(16.67% ; data not shown). All tested ESBL-Ec clinical and 
food isolates displayed resistance to ampicillin, cefazolin, and 
ceftriaxone. In contrast, all strains were susceptible to piperacil-
lin-tazobactam, flomoxef, imipenem, and meropenem. ESBL-Ec 
clinical isolates were mainly resistant to aztreonam (83.3%), 
Table 1.　Energy produces by UVA-LED in the first type (a) and the 
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Table 2.　Genotyping and antimicrobial resistance of ESBL- E. coli 
(ESBL-Ec). 12 samples of ESBL-Ec from clinical isolates (a), and six 
samples of ESBL-Ec from domestic chicken meats (b). 
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ciprofloxacin (75%), sulfamethoxazole-trimethoprim (50%), cef-
metazole (8.33%), and gentamicin (4.17%), whereas ESBL-Ec 
food isolates from domestic chicken meats were resistant to 
aztreonam (100%), sulfamethoxazole-trimethoprim (33.3%), and 
gentamicin (16.7%). ESBL-Ec food isolates were still susceptible 
to cefmetazole, cefoperazone-sulbactam, and ciprofloxacin.
Inactivation of ESBL-Ec by the first type of 365 nm UVA-LED
In the first experiment, E. coli and ESBL-Ec were inactivated 
using the first type of 365 nm UVA-LED. Figure 2 shows the 
difference in the log survival ratio of E. coli and ESBL-Ec based 
on the irradiance [low power (0.23 A) and high power (0.50 A)] 
and irradiation time (15, 30, and 45 min). 
At the circuit current of 0.23 A for 45 min, the total energy 
produced was 18.63 J/cm2 (Table 1a), and the log survival ratio 
of bacteria was different in each isolated strain. The log survival 
ratio was -0.75 ± 0.15 in E. coli clinical isolates (Fig. 2a), -0.74 
± 0.05 in ESBL-Ec clinical isolates (Fig. 2c), and -1.39 ± 0.15 
in ESBL-Ec food isolates (Fig. 2e). The circuit current was in-
creased to 0.50 A for 45 min, and the total energy produced was 
40.76 J/cm2 (Table 1a). The log survival ratio was -3.37 ± 0.29 in 
E. coli clinical isolates (Fig. 2b), -3.87 ± 0.46 in ESBL-Ec clinical 
isolates (Fig. 2d), and -3.89 ± 0.41 in ESBL-Ec food isolates (Fig. 
2f). These results indicated that 40.76 J/cm2 was the minimum 
energy dosage required to inactivate E. coli and ESBL-Ec at a 
minimum irradiation time of 45 min, and the killing ability was 
significantly increased. 
Inactivation of ESBL-Ec by the second type 365 nm UVA-LED
In the second type of UVA-LED, the UVA-LED tools system 
was improved. The difference in irradiance produced by the 
second type of UVA-LED was measured. At the circuit current 
of 0.23 A for 5 min, the total energy produced was 38.85 J/cm2 
(Table 1b), and the log survival ratio of bacteria was different in 
each isolated strain. The log survival ratio was -1.78 ± 0.16 in E. 
coli clinical isolates (Fig. 3a), -3.25 ± 0.29 in ESBL-Ec clinical 
isolates (Fig. 3b), and -2.97 ± 0.15 in ESBL-Ec food isolates (Fig. 
3c). Figures 2 and 3 indicate that UVA-LED can inactivate E. 
coli and ESBL-Ec from both clinical and environment isolates.
 
Inactivation of bacteria was dependent on the energy dosage pro-
duced by UVA-LED and irradiation time
The log survival ratio is the ability of E. coli and ESBL-Ec to 
survive after UVA-LED radiation. E. coli and ESBL-Ec using 
UVA-LED with 365 nm wavelength required high dosage en-
ergy for inactivation. High energy required high output power 
of irradiance and long irradiation time. The increase of energy 
produced by the UVA-LED system led to the decrease of the log 
survival ratio. Figure 4 shows the inactivation of E. coli and ES-
BL-Ec in an UVA-LED dose-dependent manner. There were no 
significant differences in the three regression lines between E. 
coli clinical isolate strains (Fig. 4a) and ESBL-Ec from both clin-
ical (Fig. 4b) and food (Fig. 4c) isolate strains (data not shown).
Figure 2.　The log survival ratio depends on different output power and irradiation time using the first type of 365 nm UVA-LED. E. 
coli clinical isolate group in the first line (a and b), ESBL-Ec clinical isolates group in the second line (c and d), and ESBL-Ec food iso-
lates group in the third line (e and f). The left side (a, c, e) at the low power (0.23 A) from 15 min (6.23 J/cm2), 30 min (12.47 J/cm2), and 
45 min (18.63 J/cm2). The right side (b, d, f) at the high power (0.50 A) from 15 min (13.70 J/cm2), 30 min (27.08 J/cm2), and 45 min (40.76 
J/cm2). Values are shown as means ± SD (n = 3, n = number of independent replicates).
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Figure 3.　The log survival ratio of E. coli clinical isolates group (a), ESBL-Ec clinical isolates group (b) and ESBL-Ec food isolates 
group (c), at the low power (0.23 A), in 5 min irradiation (38.85 J/cm2) using the second type of 365 nm UVA-LED. Values are shown 
as means ± SD (n = 3, n = number of independent replicates).
Figure 4.　UVA-LED Irradiation inactivation of E. coli clinical isolates (a), ESBL-Ec clinical isolates (b), ESBL-Ec food isolates (c), 
in an UVA-LED dose-dependent manner. There were no significant differences in the three regression lines (P > 0.05) between E. coli 
clinical isolate strains and ESBL-Ec, both clinical and food isolate strains. 
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DISCUSSION
In this study, we focused on the inactivation of ESBL-Ec from 
both clinical and food isolates, and we also tried to inactivate E. 
coli from clinical isolates using UVA-LED with 365 nm wave-
length. This is the first report that applied UVA-LED on E. coli 
and ESBL-Ec from clinical and food isolates.
We applied the first type of 365 nm UVA-LED device that was 
developed in our previous work (17-20,28). The killing ability 
of E. coli and ESBL-Ec was significantly increased with high 
energy dosage and long irradiation time. In the second type of 
UVA-LED, we improved the UVA-LED tools system equipped 
with three 365 nm LEDs with lenses. The lenses played a vital 
role in affecting the quality of the lighting itself. The light had 
more brightness and was more concentrated (Fig. 1f) compared 
to the first type of UVA-LED (Fig. 1d).
The energy produced by the first type of UVA-LED at 0.50 A 
after 45 min was similar to the power provided by the second 
type of UVA-LED at 0.23 A after 5 min irradiation. In the sec-
ond type of UVA-LED, higher irradiance and shorter exposure 
time led to higher inactivation efficiency at the same UVA dose 
compared to the first type of UVA-LED. Therefore, we concluded 
that the second type of UVA-LED saved more time and was ener-
gy efficient in the deactivation of E. coli and ESBL-Ec. The inacti-
vation of E. coli and ESBL-Ec in UVA-LED was dose-dependent. 
The high energy produced by output power and irradiation time 
of the UVA-LED system increased the killing ability ; thus, the 
log survival ratio of bacteria decreased.
Our UVA-LED irradiation system can inactive E. coli and ES-
BL-Ec at least 38.85 J/cm2 to achieve -3 log inactivation to reach 
safe levels (25-26). The pathogenic E. coli group has differences 
in an infective dose range that causes illness in healthy adults. 
The infectious dose of enterotoxigenic E. coli (ETEC) is estimated 
to be 108 organisms. Enteroinvasive E. coli (EIEC) at least 106 
organisms and enteropathogenic E. coli (EPEC) is estimated 
to be 106 organisms (27). Our result indicated that UVA-LED 
radiation could inactive the bacteria -3 log (108 to 105 organisms) 
reduction of E. coli or ESBL-Ec. It lower than the infective doses 
range of pathogenic E. coli group. There is no scientific standard 
that exists in the probability of ESBL-Ec infection. Many re-
sources identifying the requires UVA-LED doses for inactivation 
various pathogens can be found in numerous publications and 
studies. All existing requirements for disinfection to achieve at 
least -3 log inactivation of E. coli.
Interestingly, UVA-LED sensitivity in this study was different 
in each genotype isolated from clinical and food isolate strains. 
However, we were not able to find a significant correlation be-
tween genotyping and UVA-LED sensitivity. Therefore, for the 
next step, we plan to increase the number of ESBL-Ec from 
another isolate, such as vegetables, to get a variety of ESBL-Ec 
genotyping. Furthermore, we would want to explore the sensi-
tivity mechanism of UVA-LED on ESBL-Ec. The irradiation 
of UVA-LED induces oxidative damage of intracellular DNA or 
protein and increases 8-OHdG, a DNA oxidation product. The 
oxidative effects of UVA-LED-mediated reactive oxygen species 
are significant for bacterial inactivation (28). 
In addition, the UVA-LED radiation has been reported ef-
fected for inactivation on biofilms such as Candida albicans or 
Escherichia coli. Exposure pulsed of UVA-LED radiation at 365 
nm wavelength had more inactivation efficiency than continuous 
mode (29). The UVA-LED irradiation system has been report-
ed can killing the methicillin-resistant Staphylococcus aureus 
(MRSA), Candida aureus, bacteriophage MS2, and bacteriophage 
Phi X174. The UVA-LED irradiation at 365 nm wavelength 
shown a significant reduction of the pathogenic microorganism 
from in-use medical equipment (24). These findings suggest that 
healthcare-associated infections (HAIs) caused by antibiotic 
resistance, such as ESBL-producing Enterobacteriaceae and 
MRSA, can be reduced by UVA-LED irradiation. The results of 
this study confirm that UVA-LED radiation is a viable technolo-
gy as a disinfection system in healthcare settings.
The present study is a brief report on the ESBL-Ec incidence 
at Tokushima University Hospital. Data showed the prevalence 
and characteristics of ESBL-Ec clinical isolates at Tokushima 
University Hospital from December 2017 to June 2018 and ES-
BL-Ec food isolates in retail domestic chicken meats from May to 
June 2018 in Tokushima City. Our study presents several limita-
tions. The number of processed samples was small, and system-
atic surveillance was not used, so this study does not represent 
the overall data of ESBL-Ec incidence in Tokushima Prefecture.
CONCLUSIONS
This study can assist in developing the UVA-LED irradiation 
system as an innovative non-antibiotic approach to be applied for 
the disinfection and inactivation of pathogen-associated infec-
tious diseases in the hospitals or healthcare facilities and food 
safety systems, as this system is highly energy efficient, reliable, 
free of mercury, simple to apply, and cost-effective and has a 
much longer lifespan.
This is the first report that applied UVA-LED on E. coli and 
ESBL-Ec from clinical and food isolates. In this study, we 
demonstrated that UVA-LED was effective to inactivate E. coli 
and ESBL-Ec from clinical and food isolate strains. The inac-
tivation of bacteria was dependent on the output power of the 
UVA-LED device and irradiation time. 
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